Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery

ClinicalTrials.gov ID: NCT04739709

Public ClinicalTrials.gov record NCT04739709. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 7:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of APP13007 for the Treatment of Inflammation and Pain After Cataract Surgery

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This Phase 3 study will evaluate APP13007 in comparison to the matching vehicle placebo in a randomized, parallel-group, double-masked fashion. The subjects will have undergone routine cataract surgery on Day 0 of the study and will be assessed the next day (Post-operative Day 1; POD1) after uncomplicated surgery for eligibility for randomization to study treatment.

Study identification

NCT ID
NCT04739709
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Formosa Pharmaceuticals, Inc.
Industry
Enrollment
378 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 10, 2021
Primary completion
Mar 16, 2022
Completion
Mar 16, 2022
Last update posted
Jul 19, 2023

2021 – 2022

United States locations

U.S. sites
34
U.S. states
16
U.S. cities
31
Facility City State ZIP Site status
Schwartz Laser Eye Center Scottsdale Arizona 85260
Global Research Management Glendale California 91204
Inland Eye Specialists Hemet California 92545
SoCal Eye Physicians and Associates Long Beach California 90805
North Valley Eye Medical Group, Inc. Mission Hills California 91345
LoBue Laser and Eye Medical Center, Inc. Murrieta California 92562
Pendleton Eye Center Oceanside California 92056
Martel Eye Medical Group Rancho Cordova California 95670
Shasta Eye Medical Group, Inc. Redding California 96001
Icon Eye Care Grand Junction Colorado 81501
Levenson Eye Associates Jacksonville Florida 32204
International Eye Associates, PA Ormond Beach Florida 32174
Newsom Eye and Laser Center Sebring Florida 33870
Coastal Research Associates, LLC Roswell Georgia 30076
Jacksoneye SC Columbus Illinois 60046
Midwest Cornea Associates, LLC Carmel Indiana 46290
Senior Health Services Louisville Kentucky 40220
Silverstein Eye Centers, PC Kansas City Missouri 64133
Ophthalmology Consultants, Ltd. St Louis Missouri 63131
Comprehensive Eye Care, Ltd. Washington Missouri 63090
NV Eye Surgery Henderson Nevada 89052
Center For Sight Las Vegas Nevada 89145
Raymond Fong, MD, PC New York New York 10013
Carolina Eye Associates Southern Pines North Carolina 28387
Eye Physicians, LLC Columbus Ohio 43215
Bucci Laser Vision Institute Wilkes-Barre Pennsylvania 18702
Keystone Research Ltd. Austin Texas 78731
Retina Research Center, PLLC Austin Texas 78750
Houston Eye Associates Houston Texas 77008
Advanced Laser Vision and Surgical Institute Houston Texas 77034
Lake Travis Eye and Laser Center Lakeway Texas 78738
R and R Eye Research, LLC San Antonio Texas 78229
San Antonio Eye Center San Antonio Texas 78238
Stacy R. Smith, MD, PC Salt Lake City Utah 84117

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04739709, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 19, 2023 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04739709 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →